Healthcare

Artificial Intelligence in Medicine Market by Product Type (Hardware, Software, and Services), Technology (Deep Learning, Querying Method, Natural Language Processing, and Context Aware Processing), and Application (Drug Discovery & Repurposing, Clinical Research Trial, Personalized Medicine, and Others) - Global Opportunity Analysis and Industry Forecast, 2018-2025

  • ALL2658356
  • 231 Pages
  • July 2018
  • Healthcare
Download Sample    Get Discount   
 

The global artificial intelligence (AI) in medicine market was valued at $719 million in 2017 and is estimated to reach $18,119 million at a CAGR of 49.6% from 2018 to 2025. Artificial intelligence (AI) can be defined as a system with human intelligence-based functioning involving reasoning, learning, and problem-solving skills. AI software and different algorithms can be used to support the decision-making processes for existing drugs and repurposing drugs to treat other conditions in the field of pharmaceuticals. In addition, AI software can also be used to find the appropriate patient from several data sources, which in turn is expected to accelerate the clinical trials process.


Increase in the processing power of AI systems and shortage of skilled healthcare professionals is projected to drive the growth of the global artificial intelligence in medicine market. In addition, rise in funding of the R&D activities related to AI in medicine and growth in importance of precision medicine are expected to fuel the market growth. However, limitations of AI decision-making and limited acceptance from healthcare professionals can restrain the market growth. The presence of untapped market opportunities in emerging regions such as India and China, can provide new avenues for the growth of the artificial intelligence in medicine market.


The global artificial intelligence in medicine market is segmented based on product type, technology, application, and region. Based on product type, the market is segmented into hardware, software, and service. Based on technology, the market is classified into deep learning, querying method, natural language processing, and context aware processing. Based on application, the market is categorized into drug discovery & repurposing, clinical research trial, personalized medicine, and others. Based on region, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.


KEY MARKET BENEFITS FOR STAKEHOLDERS

  • This report entails a detailed quantitative analysis of the current market trends from 2018 to 2025 to identify the prevailing opportunities.

  • Market estimations are based on comprehensive analysis of the key developments in the industry.

  • The global market is comprehensively analyzed with respect to product type, technology, application, and region.

  • In-depth analysis based on region assists to understand the regional market to help in strategic business planning.

  • The development strategies adopted by key manufacturers are enlisted to understand the competitive scenario of the market.


KEY MARKET SEGMENTS


By Product Type

  • Hardware

  • Software

  • Service

By Technology

  • Deep Learning

  • Querying Method

  • Natural Language Processing

  • Context Aware Processing

By Application

  • Drug Discovery & Repurposing (Preclinical Phase)

  • Clinical Research Trial 

  • Personalized Medicine

  • Others

By Region

  • North America

    • U.S.

    • Canada

    • Mexico

  • Europe

    • Germany

    • France

    • UK

    • Italy

    • Spain

    • Rest of Europe

  • Asia-Pacific

    • Japan

    • China

    • Australia

    • India

    • South Korea

    • Taiwan

    • Rest of Asia-Pacific

  • LAMEA

    • Brazil

    • Saudi Arabia

    • South Africa

    • Rest of LAMEA


KEY PLAYERS PROFILED

  • Welltok, Inc.

  • Intel Corporation

  • Nvidia Corporation

  • Google Inc.

  • IBM Corporation

  • Microsoft Corporation

  • General Vision, Inc.

  • Enlitic, Inc.

  • BioXcel Corporation

  • Berg Health. 

The other players of the artificial intelligence in medicine market include (companies not profiled in the report):

  • InSilico Medicine, Inc.

  • Globavir Biosciences, Inc.

  • GNS Healthcare

  • Flatiron Health

  • Benevolent AI

  • Atomwise

  • Verge Genomics

  • Cloud Pharmaceuticals

  • Recursion Pharmaceuticals

CHAPTER 1: INTRODUCTION

1.1. Report description

1.2. Key benefits for stakeholders

1.3. Key market segments

1.4. Research methodology

1.4.1. Secondary research

1.4.2. Primary research

1.4.3. Analyst tools and models

CHAPTER 2: EXECUTIVE SUMMARY

2.1. CXO perspective

CHAPTER 3: MARKET OVERVIEW

3.1. Market definition and scope

3.2. Key findings

3.2.1. Top investment pockets

3.2.2. Top winning strategies

3.3. Porters five forces analysis

3.4. Market dynamics

3.4.1. Drivers

3.4.1.1. Increase in processing power of AI systems leading to enhanced AI capabilities

3.4.1.2. Dearth of skilled healthcare professionals

3.4.1.3. Growing importance of precision medicine

3.4.2. Restraints

3.4.2.1. Limitations of AI decision-making

3.4.2.2. Limited acceptance from healthcare professionals

3.4.3. Opportunities

3.4.3.1. Untapped market in developing regions

CHAPTER 4: ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET, BY PRODUCT TYPE

4.1. Overview

4.1.1. Market size and forecast

4.2. Hardware

4.2.1. Key market trends, growth factors and growth opportunities

4.2.2. Market size and forecast

4.2.3. Market analysis, by country

4.3. Software

4.3.1. Key market trends, growth factors and growth opportunities

4.3.2. Market size and forecast

4.3.3. Market analysis, by country

4.4. Services

4.4.1. Key market trends, growth factors and opportunities

4.4.2. Market size and forecast

4.4.3. Market analysis, by country

CHAPTER 5: ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET, BY TECHNOLOGY

5.1. Overview

5.1.1. Market size and forecast

5.2. Deep learning

5.2.1. Market size and forecast

5.2.2. Market analysis, by country

5.3. Querying method

5.3.1. Market size and forecast

5.3.2. Market analysis, by country

5.4. Natural language processing

5.4.1. Market size and forecast

5.4.2. Market analysis, by country

5.5. Context aware processing

5.5.1. Market size and forecast

5.5.2. Market analysis, by country

CHAPTER 6: ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET, BY APPLICATION

6.1. Overview

6.1.1. Market size and forecast

6.2. Drug Discovery

6.2.1. Market size and forecast

6.2.2. Market analysis, by country

6.3. Clinical Research Trial

6.3.1. Market size and forecast

6.3.2. Market analysis, by country

6.4. Personalized medicine

6.4.1. Market size and forecast

6.4.2. Market analysis, by country

6.5. Others

6.5.1. Market size and forecast

6.5.2. Market analysis, by country

CHAPTER 7: ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET, BY REGION

7.1. Overview

7.1.1. Market size and forecast

7.2. North America

7.2.1. Key market trends, growth factors and opportunities

7.2.2. North America market size and forecast, by product type

7.2.3. North America market size and forecast, by technology

7.2.4. North America market size and forecast, by application

7.2.5. North America market size and forecast, by country

7.2.5.1. U.S. market size and forecast, by product type

7.2.5.2. U.S. market size and forecast, by technology

7.2.5.3. U.S. market size and forecast, by application

7.2.5.4. Canada market size and forecast, by product type

7.2.5.5. Canada market size and forecast, by technology

7.2.5.6. Canada market size and forecast, by application

7.2.5.7. Mexico market size and forecast, by product type

7.2.5.8. Mexico market size and forecast, by technology

7.2.5.9. Mexico market size and forecast, by application

7.3. Europe

7.3.1. Key market trends, growth factors and opportunities

7.3.2. Europe market size and forecast, by product type

7.3.3. Europe market size and forecast, by technology

7.3.4. Europe market size and forecast, by application

7.3.5. Europe market size and forecast, by country

7.3.5.1. Germany market size and forecast, by product type

7.3.5.2. Germany market size and forecast, by technology

7.3.5.3. Germany market size and forecast, by application

7.3.5.4. France market size and forecast, by product type

7.3.5.5. France market size and forecast, by technology

7.3.5.6. France market size and forecast, by application

7.3.5.7. UK market size and forecast, by product type

7.3.5.8. UK market size and forecast, by technology

7.3.5.9. UK market size and forecast, by application

7.3.5.10. Italy market size and forecast, by product type

7.3.5.11. Italy market size and forecast, by technology

7.3.5.12. Italy market size and forecast, by application

7.3.5.13. Spain market size and forecast, by product type

7.3.5.14. Spain market size and forecast, by technology

7.3.5.15. Spain market size and forecast, by application

7.3.5.16. Rest of Europe market size and forecast, by product type

7.3.5.17. Rest of Europe market size and forecast, by technology

7.3.5.18. Rest of Europe market size and forecast, by application

7.4. Asia-Pacific

7.4.1. Key market trends, growth factors and opportunities

7.4.2. Asia-Pacific market size and forecast, by product type

7.4.3. Asia-Pacific market size and forecast, by technology

7.4.4. Asia-Pacific market size and forecast, by application

7.4.5. Asia-Pacific market size and forecast, by country

7.4.5.1. Japan market size and forecast, by product type

7.4.5.2. Japan market size and forecast, by technology

7.4.5.3. Japan market size and forecast, by application

7.4.5.4. China market size and forecast, by product type

7.4.5.5. China market size and forecast, by technology

7.4.5.6. China market size and forecast, by application

7.4.5.7. Australia market size and forecast, by product type

7.4.5.8. Australia market size and forecast, by technology

7.4.5.9. Australia market size and forecast, by application

7.4.5.10. India market size and forecast, by product type

7.4.5.11. India market size and forecast, by technology

7.4.5.12. India market size and forecast, by application

7.4.5.13. South Korea market size and forecast, by product type

7.4.5.14. South Korea market size and forecast, by technology

7.4.5.15. South Korea market size and forecast, by application

7.4.5.16. Taiwan market size and forecast, by product type

7.4.5.17. Taiwan market size and forecast, by technology

7.4.5.18. Taiwan market size and forecast, by application

7.4.5.19. Rest of Asia-Pacific market size and forecast, by product type

7.4.5.20. Rest of Asia-Pacific market size and forecast, by technology

7.4.5.21. Rest of Asia-Pacific market size and forecast, by application

7.5. LAMEA

7.5.1. Key market trends, growth factors, and opportunities

7.5.2. LAMEA market size and forecast, by product type

7.5.3. LAMEA market size and forecast, by technology

7.5.4. LAMEA market size and forecast, by application

7.5.5. LAMEA market size and forecast, by country

7.5.5.1. Brazil market size and forecast, by product type

7.5.5.2. Brazil market size and forecast, by technology

7.5.5.3. Brazil market size and forecast, by application

7.5.5.4. Saudi Arabia market size and forecast, by product type

7.5.5.5. Saudi Arabia market size and forecast, by technology

7.5.5.6. Saudi Arabia market size and forecast, by application

7.5.5.7. South Africa market size and forecast, by product type

7.5.5.8. South Africa market size and forecast, by technology

7.5.5.9. South Africa market size and forecast, by application

7.5.5.10. Rest of LAMEA market size and forecast, by product type

7.5.5.11. Rest of LAMEA market size and forecast, by technology

7.5.5.12. Rest of LAMEA market size and forecast, by application

CHAPTER 8: COMPANY PROFILES

8.1. Alphabet Inc. (Google Inc.)

8.1.1. Company overview

8.1.2. Company snapshot

8.1.3. Operating business segments

8.1.4. Product portfolio

8.1.5. Business performance

8.1.6. Key strategic moves and developments

8.2. Berg Health

8.2.1. Company overview

8.2.2. Company snapshot

8.2.3. Product portfolio

8.2.4. Key strategic moves and developments

8.3. BioXcel Corporation

8.3.1. Company overview

8.3.2. Company snapshot

8.3.3. Product portfolio

8.4. Enlitic Inc.

8.4.1. Company overview

8.4.2. Company snapshot

8.4.3. Product portfolio

8.4.4. Key strategic moves and developments

8.5. General Vision

8.5.1. Company overview

8.5.2. Company snapshot

8.5.3. Operating business segments

8.5.4. Product portfolio

8.5.5. Key strategic moves and developments

8.6. IBM Corporation

8.6.1. Company overview

8.6.2. Company snapshot

8.6.3. Operating business segments

8.6.4. Product portfolio

8.6.5. Business performance

8.6.6. Key strategic moves and developments

8.7. Intel Corporation

8.7.1. Company overview

8.7.2. Company snapshot

8.7.3. Operating business segments

8.7.4. Product portfolio

8.7.5. Business performance

8.7.6. Key strategic moves and developments

8.8. Microsoft Corporation

8.8.1. Company overview

8.8.2. Company snapshot

8.8.3. Operating business segments

8.8.4. Product portfolio

8.8.5. Business performance

8.8.6. Key strategic moves and developments

8.9. Nvidia Corporation

8.9.1. Company overview

8.9.2. Company snapshot

8.9.3. Operating business segments

8.9.4. Product portfolio

8.9.5. Business performance

8.9.6. Key strategic moves and developments

8.10. Welltok Inc.

8.10.1. Company overview

8.10.2. Company snapshot

8.10.3. Operating business segments

8.10.4. Product portfolio

8.10.5. Key strategic moves and developments

LIST OF TABLES

TABLE 01. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET, BY PRODUCT TYPE, 20172025 ($MILLION)

TABLE 02. ARTIFICIAL INTELLIGENCE HARDWARE IN MEDICINE MARKET, BY REGION, 20172025 ($MILLION)

TABLE 03. ARTIFICIAL INTELLIGENCE SOFTWARE IN MEDICINE MARKET, BY REGION, 20172025 ($MILLION)

TABLE 04. ARTIFICIAL INTELLIGENCE SERVICES IN MEDICINE MARKET, BY REGION, 20172025 ($MILLION)

TABLE 05. GLOBAL ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET, BY TECHNOLOGY, 20172025 ($MILLION)

TABLE 06. ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET FOR DEEP LEARNING, BY REGION, 20172025 ($MILLION)

TABLE 07. ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET FOR QUERYING METHOD, BY REGION, 20172025 ($MILLION)

TABLE 08. ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET FOR NATURAL LANGUAGE PROCESSING, BY REGION, 20172025 ($MILLION)

TABLE 09. ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET FOR CONTEXT AWARE PROCESSING, BY REGION, 20172025 ($MILLION)

TABLE 10. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET, BY APPLICATION, 20172025 ($MILLION)

TABLE 11. ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET FOR DRUG DISCOVERY, BY REGION, 20172025 ($MILLION)

TABLE 12. ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET FOR CLINICAL RESEARCH TRIAL, BY REGION, 20172025 ($MILLION)

TABLE 13. ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET FOR PERSONALIZED MEDICINE, BY REGION, 20172025 ($MILLION)

TABLE 14. ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET FOR OTHER MEDICINE APPLICATIONS, BY REGION, 20172025 ($MILLION)

TABLE 15. ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET, BY REGION, 20172025 ($MILLION)

TABLE 16. NORTH AMERICA ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET, BY PRODUCT TYPE, 20172025 ($MILLION)

TABLE 17. NORTH AMERICA ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET, BY TECHNOLOGY, 20172025 ($MILLION)

TABLE 18. NORTH AMERICA ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET, BY APPLICATION, 20172025 ($MILLION)

TABLE 19. NORTH AMERICA ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET, BY COUNTRY, 20172025 ($MILLION)

TABLE 20. U.S. ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET, BY PRODUCT TYPE, 20172025 ($MILLION)

TABLE 21. U.S. ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET, BY TECHNOLOGY, 20172025 ($MILLION)

TABLE 22. U.S. ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET, BY APPLICATION, 20172025 ($MILLION)

TABLE 23. CANADA ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET, BY PRODUCT TYPE, 20172025 ($MILLION)

TABLE 24. CANADA ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET, BY TECHNOLOGY, 20172025 ($MILLION)

TABLE 25. CANADA ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET, BY APPLICATION, 20172025 ($MILLION)

TABLE 26. MEXICO ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET, BY PRODUCT TYPE, 20172025 ($MILLION)

TABLE 27. MEXICO ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET, BY TECHNOLOGY, 20172025 ($MILLION)

TABLE 28. MEXICO ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET, BY APPLICATION, 20172025 ($MILLION)

TABLE 29. EUROPE ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET, BY PRODUCT TYPE, 20172025 ($MILLION)

TABLE 30. EUROPE ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET, BY TECHNOLOGY, 20172025 ($MILLION)

TABLE 31. EUROPE ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET, BY APPLICATION, 20172025 ($MILLION)

TABLE 32. EUROPE ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET, BY COUNTRY, 20172025 ($MILLION)

TABLE 33. GERMANY ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET, BY PRODUCT TYPE, 20172025 ($MILLION)

TABLE 34. GERMANY ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET, BY TECHNOLOGY, 20172025 ($MILLION)

TABLE 35. GERMANY ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET, BY APPLICATION, 20172025 ($MILLION)

TABLE 36. FRANCE ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET, BY PRODUCT TYPE, 20172025 ($MILLION)

TABLE 37. FRANCE ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET, BY TECHNOLOGY, 20172025 ($MILLION)

TABLE 38. FRANCE ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET, BY APPLICATION, 20172025 ($MILLION)

TABLE 39. UK ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET, BY PRODUCT TYPE, 20172025 ($MILLION)

TABLE 40. UK ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET, BY TECHNOLOGY, 20172025 ($MILLION)

TABLE 41. UK ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET, BY APPLICATION, 20172025 ($MILLION)

TABLE 42. ITALY ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET, BY PRODUCT TYPE, 20172025 ($MILLION)

TABLE 43. ITALY ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET, BY TECHNOLOGY, 20172025 ($MILLION)

TABLE 44. ITALY ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET, BY APPLICATION, 20172025 ($MILLION)

TABLE 45. SPAIN ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET, BY PRODUCT TYPE, 20172025 ($MILLION)

TABLE 46. SPAIN ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET, BY TECHNOLOGY, 20172025 ($MILLION)

TABLE 47. SPAIN ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET, BY APPLICATION, 20172025 ($MILLION)

TABLE 48. REST OF EUROPE ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET, BY PRODUCT TYPE, 20172025 ($MILLION)

TABLE 49. REST OF EUROPE ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET, BY TECHNOLOGY, 20172025 ($MILLION)

TABLE 50. REST OF EUROPE ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET, BY APPLICATION, 20172025 ($MILLION)

TABLE 51. ASIA-PACIFIC ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET, BY PRODUCT TYPE, 20172025 ($MILLION)

TABLE 52. ASIA-PACIFIC ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET, BY TECHNOLOGY, 20172025 ($MILLION)

TABLE 53. ASIA-PACIFIC ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET, BY APPLICATION, 20172025 ($MILLION)

TABLE 54. ASIA-PACIFIC ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET, BY COUNTRY, 20172025 ($MILLION)

TABLE 55. JAPAN ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET, BY PRODUCT TYPE, 20172025 ($MILLION)

TABLE 56. JAPAN ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET, BY TECHNOLOGY, 20172025 ($MILLION)

TABLE 57. JAPAN ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET, BY APPLICATION, 20172025 ($MILLION)

TABLE 58. CHINA ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET, BY PRODUCT TYPE, 20172025 ($MILLION)

TABLE 59. CHINA ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET, BY TECHNOLOGY, 20172025 ($MILLION)

TABLE 60. CHINA ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET, BY APPLICATION, 20172025 ($MILLION)

TABLE 61. AUSTRALIA ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET, BY PRODUCT TYPE, 20172025 ($MILLION)

TABLE 62. AUSTRALIA ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET, BY TECHNOLOGY, 20172025 ($MILLION)

TABLE 63. AUSTRALIA ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET, BY APPLICATION, 20172025 ($MILLION)

TABLE 64. INDIA ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET, BY PRODUCT TYPE, 20172025 ($MILLION)

TABLE 65. INDIA ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET, BY TECHNOLOGY, 20172025 ($MILLION)

TABLE 66. INDIA ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET, BY APPLICATION, 20172025 ($MILLION)

TABLE 67. SOUTH KOREA ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET, BY PRODUCT TYPE, 20172025 ($MILLION)

TABLE 68. SOUTH KOREA ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET, BY TECHNOLOGY, 20172025 ($MILLION)

TABLE 69. SOUTH KOREA ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET, BY APPLICATION, 20172025 ($MILLION)

TABLE 70. TAIWAN ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET, BY PRODUCT TYPE, 20172025 ($MILLION)

TABLE 71. TAIWAN ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET, BY TECHNOLOGY, 20172025 ($MILLION)

TABLE 72. TAIWAN ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET, BY APPLICATION, 20172025 ($MILLION)

TABLE 73. REST OF ASIA-PACIFIC ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET, BY PRODUCT TYPE, 20172025 ($MILLION)

TABLE 74. REST OF ASIA-PACIFIC ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET, BY TECHNOLOGY, 20172025 ($MILLION)

TABLE 75. REST OF ASIA-PACIFIC ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET, BY APPLICATION, 20172025 ($MILLION)

TABLE 76. LAMEA ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET, BY PRODUCT TYPE, 20172025 ($MILLION)

TABLE 77. LAMEA ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET, BY TECHNOLOGY, 20172025 ($MILLION)

TABLE 78. LAMEA ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET, BY APPLICATION, 20172025 ($MILLION)

TABLE 79. LAMEA ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET, BY COUNTRY, 20172025 ($MILLION)

TABLE 80. BRAZIL ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET, BY PRODUCT TYPE, 20172025 ($MILLION)

TABLE 81. BRAZIL ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET, BY TECHNOLOGY, 20172025 ($MILLION)

TABLE 82. BRAZIL ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET, BY APPLICATION, 20172025 ($MILLION)

TABLE 83. SAUDI ARABIA ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET, BY PRODUCT TYPE, 20172025 ($MILLION)

TABLE 84. SAUDI ARABIA ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET, BY TECHNOLOGY, 20172025 ($MILLION)

TABLE 85. SAUDI ARABIA ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET, BY APPLICATION, 20172025 ($MILLION)

TABLE 86. SOUTH AFRICA ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET, BY PRODUCT TYPE, 20172025 ($MILLION)

TABLE 87. SOUTH AFRICA ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET, BY TECHNOLOGY, 20172025 ($MILLION)

TABLE 88. SOUTH AFRICA ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET, BY APPLICATION, 20172025 ($MILLION)

TABLE 89. REST OF LAMEA ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET, BY PRODUCT TYPE, 20172025 ($MILLION)

TABLE 90. REST OF LAMEA ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET, BY TECHNOLOGY, 20172025 ($MILLION)

TABLE 91. REST OF LAMEA ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET, BY APPLICATION, 20172025 ($MILLION)

TABLE 92. ALPHABET INC.: COMPANY SNAPSHOT

TABLE 93. ALPHABET INC.: OPERATING SEGMENTS

TABLE 94. ALPHABET INC.: PRODUCT PORTFOLIO

TABLE 95. BERG HEALTH: COMPANY SNAPSHOT

TABLE 96. BERG HEALTH: PRODUCT PORTFOLIO

TABLE 97. BIOXCEL: COMPANY SNAPSHOT

TABLE 98. ENLITIC: COMPANY SNAPSHOT

TABLE 99. ENLITIC: PRODUCT PORTFOLIO

TABLE 100. GENERAL VISION: COMPANY SNAPSHOT

TABLE 101. GENERAL VISION: THREE TECHNOLOGIES

TABLE 102. GENERAL VISION: PRODUCT PORTFOLIO

TABLE 103. IBM CORPORATION: COMPANY SNAPSHOT

TABLE 104. IBM: OPERATING SEGMENTS

TABLE 105. IBM: PRODUCT PORTFOLIO

TABLE 106. INTEL CORPORATION: COMPANY SNAPSHOT

TABLE 107. INTEL CORPORATION: OPERATING SEGMENTS

TABLE 108. INTEL CORPORATION: PRODUCT PORTFOLIO

TABLE 109. MICROSOFT CORPORATION: COMPANY SNAPSHOT

TABLE 110. MICROSOFT CORPORATION: OPERATING SEGMENTS

TABLE 111. NVIDIA: COMPANY SNAPSHOT

TABLE 112. NVIDIA: OPERATING SEGMENTS

TABLE 113. NVIDIA: PRODUCT PORTFOLIO

TABLE 114. WELLTOK: COMPANY SNAPSHOT

TABLE 115. WELLTOK: PRODUCT CATEGORIES

TABLE 116. WELLTOK: PRODUCT PORTFOLIO

LIST OF FIGURES

FIGURE 01. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SEGMENTATION

FIGURE 02. TOP INVESTMENT POCKETS

FIGURE 03. TOP WINNING STRATEGIES, BY YEAR, 20152018*

FIGURE 04. TOP WINNING STRATEGIES, BY DEVELOPMENT, 20152018* (%)

FIGURE 05. TOP WINNING STRATEGIES, BY COMPANY, 20152018*

FIGURE 06. LOW BARGAINING POWER OF BUYERS

FIGURE 07. HIGH BARGAINING POWER OF SUPPLIERS

FIGURE 08. HIGH THREAT OF NEW ENTRANTS

FIGURE 09. LOW THREAT OF SUBSTITUTION

FIGURE 10. HIGH COMPETITIVE RIVALRY

FIGURE 11. COMPARATIVE SHARE ANALYSIS OF ARTIFICIAL INTELLIGENCE HARDWARE IN MEDICINE MARKET, BY COUNTRY, 2017 & 2025 (%)

FIGURE 12. COMPARATIVE SHARE ANALYSIS OF ARTIFICIAL INTELLIGENCE SOFTWARE IN MEDICINE MARKET, BY COUNTRY, 2017 & 2025 (%)

FIGURE 13. COMPARATIVE SHARE ANALYSIS OF ARTIFICIAL INTELLIGENCE SERVICES IN MEDICINE MARKET, BY COUNTRY, 2017 & 2025 (%)

FIGURE 14. COMPARATIVE SHARE ANALYSIS OF ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET FOR DEEP LEARNING, BY COUNTRY, 2017 & 2025 (%)

FIGURE 15. COMPARATIVE SHARE ANALYSIS OF ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET FOR QUERYING METHOD, BY COUNTRY, 2017 & 2025 (%)

FIGURE 16. COMPARATIVE SHARE ANALYSIS OF ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET FOR NATURAL LANGUAGE PROCESSING, BY COUNTRY, 2017 & 2025 (%)

FIGURE 17. COMPARATIVE SHARE ANALYSIS OF ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET FOR CONTEXT AWARE PROCESSING, BY COUNTRY, 2017 & 2025 (%)

FIGURE 18. COMPARATIVE SHARE ANALYSIS OF ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET FOR DRUG DISCOVERY, BY COUNTRY, 2017 & 2025 (%)

FIGURE 19. COMPARATIVE SHARE ANALYSIS OF ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET FOR CLINICAL RESEARCH TRIAL, BY COUNTRY, 2017 & 2025 (%)

FIGURE 20. COMPARATIVE SHARE ANALYSIS OF ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET FOR PERSONALIZED MEDICINE, BY COUNTRY, 2017 & 2025 (%)

FIGURE 21. COMPARATIVE SHARE ANALYSIS OF ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET FOR OTHER MEDICINE APPLICATIONS, BY COUNTRY, 2017 & 2025 (%)

FIGURE 22. ALPHABET INC.: REVENUE, 20152017 ($MILLION)

FIGURE 23. ALPHABET INC.: REVENUE SHARE BY SEGMENT, 2017 (%)

FIGURE 24. ALPHABET INC.: REVENUE SHARE BY GEOGRAPHY, 2017 (%)

FIGURE 25. IBM: REVENUE, 20152017 ($MILLION)

FIGURE 26. IBM: REVENUE SHARE BY SEGMENT, 2017 (%)

FIGURE 27. IBM: REVENUE SHARE BY GEOGRAPHY, 2017 (%)

FIGURE 28. INTEL CORPORATION: REVENUE, 20152017 ($MILLION)

FIGURE 29. INTEL CORPORATION: REVENUE SHARE BY SEGMENT, 2017 (%)

FIGURE 30. INTEL CORPORATION: REVENUE SHARE BY GEOGRAPHY, 2017 (%)

FIGURE 31. MICROSOFT CORPORATION: REVENUE, 20152017 ($MILLION)

FIGURE 32. MICROSOFT CORPORATION: REVENUE SHARE BY SEGMENT, 2017 (%)

FIGURE 33. MICROSOFT CORPORATION: REVENUE SHARE BY GEOGRAPHY, 2017 (%)

FIGURE 34. NVIDIA: REVENUE, 20162018 ($MILLION)

FIGURE 35. NVIDIA: REVENUE SHARE BY SEGMENT, 2018 (%)

FIGURE 36. NVIDIA: REVENUE SHARE BY GEOGRAPHY, 2018 (%)

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Similar Reports

Regenerative Medicine Market by Product Type (Cell Therapy, Gene Therapy, Tissue Engineering, and Small Molecule & Biologic), Material (Synthetic Material, Biologically Derived Material, Genetically Engineered Material, and Pharmaceutical), and Application (Cardiovascular, Oncology, Dermatology, Musculoskeletal, Wound Healing, Ophthalmology, Neurology, and Others) - Global Opportunity Analysis and Industry Forecast, 2017-2023

The global regenerative medicine market was valued at $5,444 million in 2016, and is estimated to reach $39,325 million by 2023, registering a CAGR of 32.2% from 2017 to 2023. Regenerative medicines are used to repair, replace, and regenerate tissues & organs that are affected owin...

  • Publish Date: May 29, 2018
  • $5370
World Medical Robotics and Computer - Assisted Surgery Market - Opportunities and Forecasts, 2015 - 2022

The medical robotics and computer-assisted surgery is a combination of equipment, accessories, software, and services that aid in performing different functions, such as robotic minimally invasive and non-invasive radiosurgeries, rehabilitation therapies, and hospital & pharmacy automation. Surgical robotics...

  • Publish Date: May 1, 2016
  • $5370